BCL2L10 Antikörper (AA 1-204)
Kurzübersicht für BCL2L10 Antikörper (AA 1-204) (ABIN2590046)
Target
Alle BCL2L10 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-204
-
Spezifität
- Human BCL2L10 / Diva.
-
Aufreinigung
- Affinity purified
-
Immunogen
-
Full length human BCL2L10, aa1-204 (NP_065129.1).
Type of Immunogen: Recombinant protein -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.2.
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for 1 year.
-
-
- BCL2L10 (BCL2-Like 10 (Apoptosis Facilitator) (BCL2L10))
-
Andere Bezeichnung
- BCL2L10 / Diva
-
Hintergrund
-
Name/Gene ID: BCL2L10
Family: Apoptosis
Synonyms: BCL2L10, BCL-B, Apoptosis regulator Bcl-B, BCLB, Bcl2-L-10, Diva not vaccine, Anti-apoptotic protein NrH, Bcl-2-like protein 10, Boo, Boo not bladder, Diva -
Gen-ID
- 10017
-
NCBI Accession
- NP_065129
-
Pathways
- Positive Regulation of Endopeptidase Activity
Target
-